1. Home
  2. IRIX vs NCEL Comparison

IRIX vs NCEL Comparison

Compare IRIX & NCEL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • IRIX
  • NCEL
  • Stock Information
  • Founded
  • IRIX 1989
  • NCEL N/A
  • Country
  • IRIX United States
  • NCEL Switzerland
  • Employees
  • IRIX N/A
  • NCEL N/A
  • Industry
  • IRIX Biotechnology: Electromedical & Electrotherapeutic Apparatus
  • NCEL Biotechnology: Pharmaceutical Preparations
  • Sector
  • IRIX Health Care
  • NCEL Health Care
  • Exchange
  • IRIX Nasdaq
  • NCEL Nasdaq
  • Market Cap
  • IRIX 20.2M
  • NCEL 18.3M
  • IPO Year
  • IRIX 1996
  • NCEL 2021
  • Fundamental
  • Price
  • IRIX $1.04
  • NCEL N/A
  • Analyst Decision
  • IRIX
  • NCEL
  • Analyst Count
  • IRIX 0
  • NCEL 0
  • Target Price
  • IRIX N/A
  • NCEL N/A
  • AVG Volume (30 Days)
  • IRIX 36.0K
  • NCEL N/A
  • Earning Date
  • IRIX 11-11-2025
  • NCEL N/A
  • Dividend Yield
  • IRIX N/A
  • NCEL N/A
  • EPS Growth
  • IRIX N/A
  • NCEL N/A
  • EPS
  • IRIX N/A
  • NCEL N/A
  • Revenue
  • IRIX $49,744,000.00
  • NCEL N/A
  • Revenue This Year
  • IRIX $9.61
  • NCEL N/A
  • Revenue Next Year
  • IRIX N/A
  • NCEL N/A
  • P/E Ratio
  • IRIX N/A
  • NCEL N/A
  • Revenue Growth
  • IRIX 0.09
  • NCEL N/A
  • 52 Week Low
  • IRIX $0.78
  • NCEL N/A
  • 52 Week High
  • IRIX $1.95
  • NCEL N/A
  • Technical
  • Relative Strength Index (RSI)
  • IRIX 42.91
  • NCEL N/A
  • Support Level
  • IRIX $1.00
  • NCEL N/A
  • Resistance Level
  • IRIX $1.10
  • NCEL N/A
  • Average True Range (ATR)
  • IRIX 0.04
  • NCEL 0.00
  • MACD
  • IRIX 0.01
  • NCEL 0.00
  • Stochastic Oscillator
  • IRIX 38.49
  • NCEL 0.00

About IRIX IRIDEX Corporation

IRIDEX Corp is involved in the business of developing, manufacturing, and marketing laser-based medical systems, delivery devices, and consumable instrumentation for ophthalmology. Its products include Lasers, Laser delivery devices, Glaucoma devices, Retinal surgical instruments, and Veterinary and ENT products. The firm also powers its products with its proprietary Micropulse technology. The company operates in only one reportable segment, Ophthalmology. It derives revenues from the sale of consoles, delivery devices, consumables, services, and support activities. The geographical segments of the company include the United States, which drives maximum revenue, Europe, and the Americas, excluding the U.S. and Asia/Pacific Rim.

Share on Social Networks: